Enhanced external counterpulsation therapy after mitral valve repair
Part of Heart & circulation clinical trials.
This trial tests a non-invasive therapy called enhanced external counterpulsation (EECP) for people who have had a mitral valve repair procedure (TEER) due to a leaky mitral valve. The goal is to see if EECP can improve how well your heart adjusts to the repaired valve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older).
- You must have moderate or severe mitral regurgitation (a leaky mitral valve).
- You must have already had a transcatheter mitral valve repair (TEER) procedure.
- You must not have moderate or severe aortic stenosis or aortic insufficiency (problems with your aortic valve).
- You must not have severe pulmonary hypertension (mean pressure over 50 mmHg) or blood clots in your legs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clip-based procedure (TEER) to fix a severe leak in the mitral valve for people who have symptoms or heart changes but are at low to medium risk for surgery. The goal is to see if this less invasive option works well and is safe.
This trial tests a catheter-based procedure to repair a leaking mitral valve in people who are in severe heart shock and need medication support. The goal is to reduce the valve leak and see if it helps patients stabilize and recover.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
This study tests a new clip procedure (CardioClip) to repair a leaky mitral valve in people with heart failure. It aims to see if the clip can improve symptoms and heart function.
This trial tests a clip procedure to fix a leaky heart valve in people who also have a heart condition called ATTR-CM, which can cause heart failure. The clip is placed without open-heart surgery to help improve symptoms and quality of life.
This study tests a new catheter-based system to treat severe mitral valve leaking when open-heart surgery is considered high risk. It may help improve blood flow and symptoms by repairing the valve without open surgery, using ultrasound guidance and follow-up visits to track safety and results.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.